Skip to nav Skip to content

CDC/IDSA COVID-19 Clinician Call: Update on Serology Testing

Facebook Twitter LinkedIn Email

To Download a copy of the presentation click here.

Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA

Topics and Featured Experts:

CDC Update & Setting the Stage: The Use of Serology Testing to Guide Clinical Decision-Making
Adi Gundlapalli, MD, PhD
CDC COVID-19 Response Team
Chief Public Health Informatics Officer, Center for Surveillance, Epidemiology, and Laboratory Services
U.S. Centers for Disease Control and Prevention

FDA Update
Ryan Karsner, MD
Medical Officer, Division of Microbiology Devices
Office of In Vitro Diagnostics and Radiological Health
Office of Health Technology 7
Center for Devices and Radiological Health
U.S. Food and Drug Administration

Patterns of Testing at Mayo Clinic
Elitza S. Theel, PhD, D(ABMM)
Director, Infectious Diseases Serology Laboratory
Co-Director Vector-Bourne Diseases Laboratory Service Line
Professor, Laboratory Medicine and Pathology
Division of Clinical Biology
Mayo Clinic

The Clinical Perspective: Using Serology Test to Guide Clinical Decision-Making
Ghady Haidar, MD
Director of Research, Bone Marrow Transplant and Hematological Malignancy Infectious Diseases
Program Director of the Transplant Infectious Diseases Fellowship Program
University of Pittsburgh

Key Considerations & Future Directions in Serology Testing
Florian Krammer, PhD
Professor of Vaccinology, Department of Microbiology
Icahn School of Medicine at Mount Sinai

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.